Welcure Drugs

Welcure_Drugs03 May 2024

Pharmaceuticals

₹

+0.13 (+2.93%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Welcure Drugs

Welcure Drugs

Pharmaceuticals

Welcure_Drugs03 May 2024

₹

+0.13 (+2.93%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
28-Mar-2024	BC	Outcome of meeting POM 04/05/2024 (As Per BSE Bulletin Dated on 01.04.2024) postal ballot notice (As Per BSE Announcement Dated on 02.04.2024)	02-May-2024
22-Mar-2024	BC	WELCURE DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/03/2024 inter alia to consider and approve To Consider and Approve th	28-Mar-2024
22-Mar-2024	BC	Resignation of Ms. Priti rajesh kharwar outcome of meeting change in management (As Per BSE Announcement dated on 28.03.2024)	28-Mar-2024
01-Feb-2024	BC	WELCURE DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve With reference to Regulati	14-Feb-2024
15-Feb-2024	BC	We hereby submit disclosures under Regulation 30 of SEBI (LODR) Regulations, 2015 regarding appointment of Directors and CFO of the Company. RESIGNATION OF DIRECTOR Resignation of Managing Dire	14-Feb-2024

No Rights has been declared by Welcure_Drugs

Book Closure

Record Date	Split Date	Purpose
02-May-2024	01 Jan'1900	Outcome of meeting POM 04/05/2024 (As Per BSE Bulletin Dated on 01.04.2024) postal ballot notice (As Per BSE Announcement Dated on 02.04.2024)
28-Mar-2024	-	WELCURE DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/03/2024 inter alia to consider and approve To Consider and Approve th
28-Mar-2024	-	Resignation of Ms. Priti rajesh kharwar outcome of meeting change in management (As Per BSE Announcement dated on 28.03.2024)
14-Feb-2024	-	WELCURE DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve With reference to Regulati
14-Feb-2024	-	We hereby submit disclosures under Regulation 30 of SEBI (LODR) Regulations, 2015 regarding appointment of Directors and CFO of the Company. RESIGNATION OF DIRECTOR Resignation of Managing Dire

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Welcure Drugs & Pharmaceuticals Ltd ₹4.57(+0.13/2.93%)	4.57	+0.13	6.17	14.82	0.00	4.23
Astrazeneca Pharma India Ltd ₹5,424.45(+90.60/1.70%)	5,424.45	+90.60	13,561.13	71.45	85.02	20.71
Bliss GVS Pharma Ltd ₹119.10(-10.10/-7.82%)	119.10	-10.10	1,246.87	56.07	18.27	1.28
Cipla Ltd ₹1,424.75(+5.20/0.37%)	1,424.75	+5.20	115,033.60	54.70	34.98	4.44
Amrutanjan Health Care Ltd ₹775.50(-11.10/-1.41%)	775.50	-11.10	2,242.02	27.78	50.95	8.56
Abbott India Ltd ₹26,144.45(-459.90/-1.73%)	26,144.45	-459.90	55,556.96	15.92	48.50	17.87

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	0.00	0.00	0.00	0.00	0.00	0.00
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	0.00	0.00	0.00	0.00	0.00	0.00
Other Operating Income	0.03	0.00	0.00	0.00	0.00	0.00
Other Income	0.00	0.00	0.00	0.05	0.01	0.01
Total Income	0.04	0.00	0.00	0.05	0.01	0.01
Total Expenditure	0.06	0.09	0.03	0.04	0.01	0.02
PBIDT	-0.02	-0.08	-0.03	0.01	0.00	-0.01
Interest	0.00	0.00	0.00	0.00	0.00	0.00
PBDT	-0.02	-0.09	-0.03	0.01	0.00	-0.01
Depreciation	0.01	0.01	0.00	0.00	0.00	0.00
Tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Profit After Tax	-0.03	-0.10	-0.03	0.01	0.00	-0.01
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	-0.03	-0.10	-0.03	0.01	0.00	-0.01

EPS (Unit Curr.)	-0.02	-0.01	-0.02	0.00	0.00	0.00
EPS (Adj) (Unit Curr.)	-0.02	-0.01	-0.02	0.00	0.00	0.00
Calculated EPS (Unit Curr.)	-0.02	-0.07	-0.02	0.01	0.00	0.00
Calculated EPS (Adj) (Unit Curr.)	-0.02	-0.07	-0.02	0.01	0.00	0.00
Calculated EPS (Ann.) (Unit Curr.)	-0.08	-0.28	-0.10	0.04	-0.01	-0.02
Calculated EPS (Adj) (Ann.) (Unit Curr.)	-0.08	-0.28	-0.10	0.04	-0.01	-0.02
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	13.44	13.44	13.44	13.44	13.44	13.44
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	0.00	0.00	0.00	0.00	0.00	0.00
PBDTM(%)	0.00	0.00	0.00	0.00	0.00	0.00
PATM(%)	0.00	0.00	0.00	0.00	0.00	0.00

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	13.44	12.12	12.12	12.12	12.12	12.12
Reserves Total	-11.92	-12.03	-12.05	-12.10	-12.09	-12.10
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	1.52	0.09	0.07	0.02	0.03	0.02
Secured Loans	0.00	0.00	0.00	0.00	0.00	0.00
Unsecured Loans	0.00	0.00	0.00	0.00	0.00	0.00
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00
Total Liabilities	1.52	0.09	0.07	0.02	0.03	0.02
APPLICATION OF FUNDS :
Gross Block	0.06	0.00	0.00	0.00	0.00	0.00
Less : Accumulated Depreciation	0.00	0.00	0.00	0.00	0.00	0.00
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	0.06	0.00	0.00	0.00	0.00	0.00
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	0.00	0.00	0.00	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.17	0.00	0.00	0.00	0.00	0.00
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	0.00	0.00	0.00	0.00	0.00	0.00
Sundry Debtors	0.00	0.00	0.00	0.00	0.00	0.00
Cash and Bank	0.00	0.07	0.05	0.01	0.01	0.01
Loans and Advances	0.00	0.00	0.00	0.02	0.01	0.01
Total Current Assets	0.01	0.07	0.05	0.02	0.03	0.02
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	0.01	0.00	0.00	0.01	0.01	0.00
Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Total Current Liabilities	0.01	0.00	0.00	0.01	0.01	0.00
Net Current Assets	-0.01	0.06	0.04	0.01	0.02	0.02
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Liability	0.00	0.00	0.00	0.00	0.00	0.00
Net Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Total Assets	0.22	0.06	0.04	0.01	0.02	0.02
Contingent Liabilities	0.00	0.00	0.00	0.00	0.00	0.00

Column	Mar 08	Mar 07	Mar 06	Mar 05	Mar 04	Mar 03
SOURCES OF FUNDS :
Share Capital	12.12	12.11	12.11	12.04	12.04	12.04
Reserves Total	-5.29	-3.36	-2.49	-0.52	-0.64	-1.19
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	6.83	8.75	9.62	11.52	11.40	10.85
Minority Interest	0.00	0.00	0.00	0.00	0.00	0.00
Secured Loans	2.76	3.73	1.76	0.58	2.92	2.49
Unsecured Loans	0.00	0.00	2.03	0.00	0.00	0.00
Total Debt	2.76	3.73	3.79	0.58	2.92	2.49
Policy Holders Fund	0.00	0.00	0.00	0.00	0.00	0.00
Other Liabilities	0.00	0.00	0.00	0.00	0.00	0.00
Total Liabilities	9.59	12.48	13.41	12.10	14.32	13.34
APPLICATION OF FUNDS :
Gross Block	6.02	6.41	6.70	7.20	7.69	5.60
Less: Accumulated Depreciation	0.00	0.00	0.00	0.00	0.00	0.00
Less: Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	6.02	6.41	6.70	7.20	7.69	5.60
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	0.00	0.00	0.00	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.28	0.38	0.38	0.37	0.28	0.28
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	0.72	1.55	2.69	1.60	3.97	5.67
Sundry Debtors	8.69	8.07	5.05	2.02	3.35	4.58
Cash and Bank	0.10	0.16	0.19	0.10	0.11	0.18
Loans and Advances	1.54	2.01	1.93	1.93	1.49	0.94
Total Current Assets	11.05	11.79	9.86	5.65	8.92	11.37
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	7.76	7.01	4.69	1.10	2.69	4.32
Provisions	0.00	0.00	0.04	0.02	0.01	0.00
Total Current Liabilities	7.76	7.01	4.73	1.12	2.70	4.32
Net Current Assets	3.29	4.78	5.13	4.53	6.22	7.05
Miscellaneous Expenses not written off	0.00	0.91	1.21	0.02	0.04	0.41
Deferred Tax Assets	0.00	0.00	0.00	0.00	0.09	0.00
Deferred Tax Liability	0.00	0.00	0.01	0.02	0.00	0.00
Net Deferred Tax	0.00	0.00	-0.01	-0.02	0.09	0.00
Other Assets	0.00	0.00	0.00	0.00	0.00	0.00
Total Assets
Contingent Liabilities	0.00	0.00	0.00	0.00	0.00	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	0.07	0.05	0.01	0.02	0.01
Net Cash from Operating Activities	0.11	0.02	0.04	-0.01	0.00
Net Cash Used In Investing Activities	1.32	0.00	0.00	0.00	0.00
Net Cash Used In Financing Activities	-1.49	0.00	0.00	0.00	0.00
Net Inc./Dec In Cash And Cash Equivalents	-0.06	0.02	0.04	-0.01	0.00
Cash And Cash Equivalents At End Of The Year	0.00	0.07	0.05	0.01	0.01

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

0.00%

FII Shareholding

0.00%

DII Shareholding

0.00%

Public Shareholding

100.00%

**Promoter pledged shareholding 0.00%

About Welcure Drugs & Pharmaceuticals Ltd

Welcure Drugs & Pharmaceuticals Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 6.17 crores. It has reported a sales of Rs. 0 crores and a net profit of Rs. -0.03 crores for the quarter ended December 2018. The company management includes , Gagan Juneja,Mohd. Shahbaz Alam,Sitaben S Patel,Rajeev Mehra,Vishal Mehra,Manowar Ali (Welcure Drugs & Pharmaceuticals Ltd) among others.

Chairman

Registered office

B-9 & 10 Laxmi Towers,L S C Block-C Saraswati Vihar,Delhi,New Delhi,110034

FAX :91-011-2702 3256

Background

Incorporation Year1996

Face Value₹10

Market Lot1

How to buy Welcure Drugs shares on nse?

To buy Welcure Drugs shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Welcure Drugs share price today?

The Welcure Drugs shares price on nse is Rs.4.57 today.

What is the market cap of Welcure Drugs shares on BSE ?

The company has a market capitalization of Rs.6.17Cr

What is the PE & PB ratio of Welcure Drugs shares ?

PE is 0 and PB is 4.23

What is the 52 Week High and Low of Welcure Drugs shares?

Welcure Drugs stock price high: Rs.5.48 Welcure Drugs stock price low: Rs.3.2